Epigenetic Mechanisms in Vascular Inflammation: Modulation of Endothelial Adhesion Molecules and Endothelium-Leukocyte Adhesion.


Journal

Frontiers in bioscience (Landmark edition)
ISSN: 2768-6698
Titre abrégé: Front Biosci (Landmark Ed)
Pays: Singapore
ID NLM: 101612996

Informations de publication

Date de publication:
06 09 2023
Historique:
received: 30 05 2023
revised: 12 07 2023
accepted: 24 07 2023
medline: 2 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: ppublish

Résumé

The endothelium, an essential component of the vascular system, plays a critical role in the inflammatory response. Under pro-inflammatory stimuli, endothelial cells undergo activation and dysfunction, leading to the release of inflammatory mediators and upregulation of cell adhesion molecules. These changes facilitate the adhesion, rolling, and transmigration of leukocytes into the subendothelial space. Emerging evidence suggests that epigenetic mechanisms, including nucleic acid methylation, post-translational histone modifications, and non-coding RNA, contribute significantly to the regulation of vascular inflammation and expression of cell adhesion molecules. Understanding the epigenetic molecular signatures that govern these processes may provide new insights into the development of therapeutic strategies to combat vascular inflammation and associated diseases. This review aims to summarize the current knowledge on the epigenetic mechanisms involved in modulating the intricate processes underlying vascular inflammation, with a specific focus on the expression of endothelial adhesion molecules and endothelium-leukocyte adhesion.

Identifiants

pubmed: 37796707
pii: S2768-6701(23)00979-6
doi: 10.31083/j.fbl2809194
doi:

Substances chimiques

Vascular Cell Adhesion Molecule-1 0
Intercellular Adhesion Molecule-1 126547-89-5
Cell Adhesion Molecules 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

194

Informations de copyright

© 2023 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

Given their roles as Guest Editors, Nadia Calabriso and Maria Annunziata Carluccio, had no involvement in the peer-review of this article and have no access to information regarding its peer-review. The authors declare no conflict of interest.

Auteurs

Nadia Calabriso (N)

Institute of Clinical Physiology (IFC), National Research Council (CNR), 73100 Lecce, Italy.

Marika Massaro (M)

Institute of Clinical Physiology (IFC), National Research Council (CNR), 73100 Lecce, Italy.

Egeria Scoditti (E)

Institute of Clinical Physiology (IFC), National Research Council (CNR), 73100 Lecce, Italy.

Chiara Carluccio (C)

Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, 35128 Padua, Italy.

Tiziano Verri (T)

Department of Biological and Environmental Sciences and Technologies (DISTEBA), University of Salento, 73100 Lecce, Italy.

Maria Annunziata Carluccio (MA)

Institute of Clinical Physiology (IFC), National Research Council (CNR), 73100 Lecce, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH